Sei sulla pagina 1di 15

Presentation of VivaSant

A Family Group
Focused on Long-Term Growth and International Development
BTG Industries & Sant is a French family office fully owned by the Le
Lous family
The business traces its origins in 1949 when Jean Le Lous becomes
the Chairman of Laboratoires Fournier Sarl, that will turn in less than
50 years the 4th independent pharmaceutical player in France

H. Le Lous
Chairman

Soon enough in 1958, operations of the Group were divided in two


core businesses:
Fournier Pharma, the ethical division
Laboratoires Urgo, that will become leader in wound treatment
In 2006, VivaSant divested Fournier Pharma to Solvay Group and recentered its activities on 2 poles:

Advanced Wound Management

P. Moustial
COO

Self-Medication
C. Arend
CFO

-3-

The DNA of VivaSant


VivaSant has a corporate culture underpinned by its DNA, at the center is Innovation

Entrepreneurship

Consumer focus

We encourage entrepreneurs
initiatives and audacity. We
strongly believe that to succeed,
you should test, try and think out
of the box

Consumer is the cornerstone


of our business. We work
continuously with one
objective: to bring the most
suitable answers to his
needs and ailments

Innovation
Adaptability

Excellence

To succeed worldwide, to
maintain a leading position
on our markets, we have to
be flexible and to keep our
eyes and ears open

Offering best in class


products, looking for a
number 1 position

-4-

VivaSant Group structure


Four business units generating 520M worldwide

2013 sales : 517 M


2 200 people
Speciality Care

Consumer Healthcare

Hospital & Community

Pharmacies

194M

2011163M
: 118M

Retail, Mass Market

126M

2011 : 109M

1650 people

350 people

-5-

Natural Health &


herbal medicine

2011
: 31M
34M

180 people

Urgo Medical
N3 on the European Advanced Wound Care Market

Urgo medical provides gold standard dressings for the


treatment of serious incapacitating solutions :
Burns
Leg ulcers
Epidermolysis bullosa
Diabetic foot ulcers
Pressure sores

Starting this activity in 2000, Urgo Medical revolutionised


the wound healing market by inventing UrgoTul , a dressing
based on the Technology Lipido Colloid (TLC) for the
management of acute and chronic wounds :
Healing in a moist environment
Promoting fibroblast proliferation
Easy to remove with pain-free dressing changes
Protecting and improving the surrounding skin
Now most prescribed product on the European Advanced
Wound Care market

-6-

A the heart of Urgo Medical success: the TLC Technology


A unique combination of hydrocolloid and lipid particles on a non-occlusive polyester mesh

-7-

Urgo Medical
N3 on the European Advanced Wound Care Market

Urgo Medic was then developed as the booster version of


TLC for diabetic, arteritic and venous insufficient patients:
NOSF component designed to neutralize excess proteases,
therefore rebalancing wound equilibrium and accelerating
wound healing
Urgo Start benefited from the first-ever comparative
randomised, controlled, double-blind study, which showed that
UrgoStart speeds up wound healing X2

In 2011, we launched UrgoClean


, an ultra-absorbent
dressing with hydro-desloughing fibres for sloughy exuding
wounds:
Clean the wound, absorbs exudates and traps slough
Traps bacteria

-8-

Urgo Medical
Strategy: to have one dressing for each requirement

Thanks to this strategy and commitment, Urgo Medical became in less than 10 years N1 in
France and N 3 on the European
Advanced Wound Care market
-9-

Humex - Humer
The Specialist of Ear Nose and Throat pathologies

Distribution in pharmacies

2 leading brands: Humex and


Humer

85% brand awareness

Cough &
Cold
Complete range
for cold
treatment,
cough, sore
throats and flulike symptom

Allergies
Allergies,
hay fever,
allergic rhinitis,
allergic
conjunctivitis

Sea Water
Spray
The very best
of the sea water
for ear/nose
hygiene and
nasal
decongestion

Best in class products for treatment


of upper respiratory track disorders
OTC and Medical Devices status
N1 in France on the allergy market
Strong presence in Romania,
Ukraine, Baltic States and North
Africa

- 10 -

Urgo & Mercurochrome


N1 in France in first aid and wound treatment

First-aid:
Plasters &
Antiseptics
Leading brand for
wound care

Mercurochrome: 98% brand awareness in France.


N1 in modern trade and mass market
Mouthcare,
Hand & Foot
Liquid plasters and
dedicated solutions for
skin cracks,
cold sores, damaged
nails, scars and mouth
ulcers

Urgo: 85% brand awareness in France. N1 in


pharmacies
Through these 2 brands, VivaSant built a solid
reputation in wound care, revolutionising the
traditional dressings market with innovative forms,
such as its Filmogel (liquid dressing), and
expanding its treatment ranges to include mouth
wounds, pain relief and support
Voted most innovative OTC pharmaceutical
company by pharmacists 3 years in succession
Strong presence in Portugal, Spain, Baltic States and
Vietnam

- 11 -

Juvamine and Alvityl


Prevention and Nutrition expertise

93% brand awareness

Prevention &
Nutrition Health
Health
Immune defences
Balance & energy

Food supplements

Balance, energy,
Vitamins & Minerals, Slimming and
Herbal therapy

pioneer of
dietary supplements products in
mass market (multivitamins,
Omega 3, nutrition, herbal
products, etc.).
Leading brand in French
supermarkets with more than
60% market shares
complex of
multivitamins prescribed and
recommended by paediatricians
Several other brands for wellbeing: OM3, Immunostim

- 12 -

Super Diet
Specialist in natural and organic products for self-prescription
Dietary supplement with natural and organic active principles
Major brands in phytotherapy, natural medication and self-medication
High-end products (clinical studies, highly concentrated products, easy to use)

Products sold in pharmacies, organic and dietetic shops

Distribution in specialised stores

- 13 -

Our leading positions in France in short

- 14 -

The success stories of our brands around the world


Vietnam

N1 on traditional plasters (over 2M sales)

Czech Republic

N1 on blister plasters with 48,5% MS

Algeria

More than 100Ku of Urgo Mouth Ulcer sold in 2012.

98% brand awareness among pharmacists

Belgium

93% brand awareness among pharmacists

Vietnam

N2

Ukraine

More than 1Mn units sold in 2012 with 48% MS

Baltic States

N1 on the sea water market

Romania

N2 on the sea water and cough & cold market

Algeria

N1 with 36,2% MS

with over 200ksales (launch in 2010)

41% brand awareness amoung consumers


99% brand awareness among GPs

- 15 -

VivaSant in summary

France is a land of excellence for healthcare. A


network of researchers in all our fields of
interest, highly efficient healthcare institutions
and a firmly established industrial tradition
form the fundations on which VivaSant has
built its success
Every man and woman working at VivaSant is
firmly committed to safety and efficacy of our
product lines. Our shared determination is to
have recognized solutions to each ailment of
the day to day life and to be in each country
where we enter, the partner for health of
every patient

- 21 -

Potrebbero piacerti anche